Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
FcRn Blockers in gMG A Case-Study
7
Mins
May 2025
Generalised myasthenia gravis (gMG) is a rare and chronic IgG-mediated autoimmune neuromuscular disease that causes fluctuating and…
Read more
2
Mins
11 Feb 2025
Targeting Tau in Early Alzheimer’s Disease
Phase 2 randomised controlled trial (RCT) of BMS-986446, a monoclonal antibody targeting the tau microtubule binding region (MTBR)…
5
Mins
24 Jan 2025
Early Intervention in MS
A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…
8
Mins
16 Jan 2025
Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied…
9
Mins
12 Dec 2024
The CORE-VNS study: Design and Interim Analysis
This article summarises a LivaNova-sponsored symposium entitled ‘The Power of Real-World Evidence with CORE-VNS’, delivered on 7th…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
4 Oct 2024
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
12 Sep 2024
Early Recognition, Diagnosis, and Treatment of Friedreich Ataxia
6
Mins
27 Aug 2024
Understanding Developmental and Epileptic Encephalopathies
Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…
8
Mins
13 Aug 2024
Reimagining Myasthenia Gravis Care
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…
8
Mins
13 Aug 2024
Update on Daridorexant for Insomnia
During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…
2
Mins
13 Aug 2024
Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study
Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…
5
Mins
13 Aug 2024
Diagnosing Synucleinopathies
Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease (AD), with an estimated…
9
Mins
13 Aug 2024
Patterns of Laryngeal Changes on Clinical Application of Mechanical Insufflation-Exsufflation
Individuals with neuromuscular diseases (NMD), where deterioration in bulbar function coexists with respiratory muscle weakness, are at…
10
Mins
13 Aug 2024
A Rare Case of Cervical Intramedullary Spinal Cord Abscess
The occurrence of intramedullary spinal cord abscesses (ISCA) is rare, a phenomenon attributable to a confluence of physiological and…
5
Mins
13 Aug 2024
Bromocriptine in the Management of Central Hyperthermia
Fever is a common medical issue encountered in neurorehabilitation units. The most common cause of fever is infection; the common…
7
Mins
1 Aug 2024
Interview: Kailash Bhatia
I completed my neurology training in Mumbai, India. At the end of my general medical degree, I was influenced by a top-rate neurologist…
6
Mins
19 Jul 2024
Roundtable Interview: Olivier Rascol and Wassilios Meissner
When I started as a neurologist and a clinical pharmacologist, there were a lot of interesting developments in movement disorders…
9
Mins
13 Jun 2024
Balancing Exercise and Contraction-induced Muscle Injury in Muscular Dystrophies
The rare diseases Duchenne and Becker are X-linked recessive neuromuscular disorders.1 They are characterised by progressive…
8
Mins
19 Mar 2024
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Masterclass Event Summary
A masterclass initiated, organised, and funded by UCB, sought to advance understanding and expertise of myelin oligodendrocyte…
8
Mins
15 Mar 2024
Impact of Non-Seizure Symptoms in Dravet Syndrome and Lennox-Gastaut Syndrome
Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…
8
Mins
14 Dec 2023
Spasticity Following Acute Stroke
Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia…
8
Mins
14 Dec 2023
Tackling Becker Muscular Dystrophy
First described by German physician Peter Emil Becker in the 1950s, Becker is an X-linked genetic recessive disorder. Like Duchenne…
7
Mins
20 Nov 2023
A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…
11
Mins
4 Oct 2023
Lennox–Gastaut Syndrome: Challenges in Diagnosis – Interviews with Two Key Opinion Leaders
Lennox–Gastaut syndrome (LGS) is a severe childhood-onset epilepsy syndrome that can be challenging to identify due to its heterogeneous and..
13
Mins
14 Sep 2023
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
6
Mins
14 Sep 2023
Assessment of Post-Traumatic Stress Disorder in Patients Who Recovered from COVID-19
It is essential to address psychological health, particularly post-traumatic stress disorder (PTSD), among patients who have recovered from…
11
Mins
15 Aug 2023
Focal Onset Seizures: New Treatment Options in The Clinical Practice
Carreño began by discussing the spectrum of uncontrolled epilepsies. They stressed that uncontrolled epilepsy does not necessarily…
15 Aug 2023
Retracted: A Spotlight on Friedreich Ataxia: Optimising the Patient Journey from Diagnosis to Disease Management
This article has now been retracted and a retraction statement has been published.
6
Mins
15 Aug 2023
Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia
In the rare neuromuscular disorders classed as NDM, muscle stiffness (myotonia) is the major symptom and is defined by a delayed muscle…
8
Mins
15 Aug 2023
Mitochondrial DNA Maintenance Disorders: Impact of Impaired Deoxynucleoside Triphosphates Metabolism
The maintenance of mitochondrial DNA (mtDNA) is dependent upon several nuclear gene-encoded proteins including enzymes forming the…
4
Mins
15 Aug 2023
Interview: Hugh Selsick
My science degrees were pivotal in fuelling my passions and setting out my career path. During my undergraduate physiology degree…
7
Mins
15 Aug 2023
Cerebrotendinous Xanthomatosis: A Clinical Series Illustrating the Radiological Findings
Cerebrotendinous xanthomatosis (CTX) is a unique disease with an autosomal recessive inheritance, occurring due to the accumulation…
7
Mins
15 Aug 2023
Study for Assessment of Mental Health in Survivors of COVID-19
COVID-19 infection was first reported in December 2019 in Wuhan, China, as a pneumonia outbreak presenting with fever…
6
Mins
15 Aug 2023
Lymphoma of Nervous System or the Great Imitator in Neurology
Primary and secondary lymphoma of the central nervous system (CNS) is a rare case of non-Hodgkin lymphoma. The World…
7
Mins
13 Jul 2023
Isolated Sacral Tuberculosis: A Rare Case Report and
Literature Review
Tuberculosis (TB) is an infectious disease caused by the transmission of Mycobacterium tuberculosis bacillary complex…
8
Mins
3 May 2023
Editor's Pick: Orthostatic Hypotension and Concomitant Paraneoplastic Syndromes: A Case Report
Paraneoplastic autonomic neuropathy is a syndrome with an unclear aetiology and wide array of symptoms. Some studies have identified a strong autoimmune component in the development of paraneoplastic autonomic neuropathy, though some aetiologies are non-immune in nature.
2
Mins
2 Mar 2023
From CoNFLict to Confidence: Solving a Diagnostic Dilemma Using Neurofilament Light – A Case Report
Measurement of fluid biomarkers of neurodegeneration is an emerging approach offering improved diagnostic accuracy of neuropsychiatric conditions, particularly for atypical presentations. This article reports a case where the diagnosis of delirium with dementia was revised based on biomarker analysis, enabling treatment of a primary mood disorder with resolution of recurrent disabling psychiatric symptoms.
8
Mins
20 Feb 2023
Benzodiazepines in Dementia: Review of Clinical Evidence
In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), Alzheimer’s disease (AD [named after the German psychiatrist and neuropathologist, Alois Alzheimer, who first described it]), is considered as a major or mild neuro-cognitive disorder…
5
Mins
17 Feb 2023
Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis
Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.
11
Mins
31 Jan 2023
The Efficacy and Safety of SARS-CoV-2 Vaccinations in People with Multiple Sclerosis
While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).
7
Mins
8 Dec 2022
Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose Adjustment
Fox emphasised that PD is one of the fastest-growing neurological disorders. Disability and deaths related to it have more than doubled from 1990–2015. Its prevalence is expected to grow exponentially by 2040, affecting approximately 12.9 million individuals worldwide.
10
Mins
8 Dec 2022
The Pathophysiological Relationship Between Migraine and SARS-CoV-2 Infection
People with migraine, and individuals with other neurological conditions, have suffered in multiple aspects during the COVID-19 pandemic. This paper will discuss the factors that impacted the neurology department.
13
Mins
8 Dec 2022
Mexiletine in the Treatment of Non-dystrophic Myotonia: Interviews with Six Medical Experts
NDM includes a group of rare hereditary neuromuscular disorders caused by mutations in the genes that encode sodium or chloride muscle channels.1 Myotonia is the hallmark symptom of NDM and presents as muscle stiffness, often associated with pain, fatigue, and weakness, which can limit function.
9
Mins
8 Dec 2022
Adult-Onset Idiopathic Cervical Dystonia
Adult-onset idiopathic focal dystonia is the most common type of primary dystonia, and adult-onset idiopathic cervical dystonia (AOICD) is its most prevalent phenotype.
11
Mins
20 Sep 2022
Cotard’s Delusion with Sequelae of Adult Onset Failure to Thrive: A Case Report
Patients can present with chief complaints and symptoms that differ from the eventual diagnoses. The differences between aetiologies versus complications must be appreciated through careful evaluation and use of clinical investigations, laboratory testing, trial of hypotheses, and clinical gestalt.
8
Mins
22 Aug 2022
Diencephalic Syndrome: Anaesthetic Management and Post-Operative Complications
Diencephalic syndrome (DS), first described by Russell in 1951, is a rare cause of failure to thrive in infants and young children with preservation of linear growth.
9
Mins
9 Aug 2022
Implications of the First Ex Vivo Gene Therapy Approved for Treating Early-Onset Metachromatic Leukodystrophy
MLD is caused by an accumulation of sulfatides in various organs and predominantly the central nervous system (CNS). Patients have an initial period of normal development, then experience developmental delay or stagnation (Figure 1).
11
Mins
9 Aug 2022
Improving The Management of Non-dystrophic Myotonia to Benefit Care Delivery and Improve Patient Outcomes
Non-dystrophic myotonias (NDM) are a group of rare muscle disorders with a reported prevalence of 0.75−1.7 per 100,000 population (Figure 1).
9
Mins
9 Aug 2022
Sex-Related Differences in Symptoms Among Patients Presenting with Acute Stroke: A Systematic Review and Meta-analysis
Recognising acute stroke symptoms is crucial in providing timely treatment. However, evidence suggests that females often experience unique symptoms compared with males, resulting in delays to seeking medical attention and treatment.
6
Mins
9 Aug 2022
Never Too Late to Treat NMDAR Encephalitis: A Paediatric Case Report and Review of Literature
Dysfunction of N-methyl-D-aspartate receptors (NMDAR) have been proposed as the aetiology for multiple neuropsychiatric diseases. While overactivity of NMDA receptors causing excitotoxicity has been implicated in epilepsy, dementia, and stroke, low activity may produce symptoms resembling those of schizophrenia.
9
Mins
25 Apr 2022
Editor's Pick: Adiposity and Neurological Disorders: A Review
Obesity and increased adipose tissue are linked with inflammation, the driving force behind neurologic disorders like Alzheimer’s disease…
4
Mins
28 Feb 2022
A Rare Case of Multiple Cranial Nerve Palsies as the First Presentation of Hepatocellular Carcinoma: A Case Report and Review of Literature
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It mainly occurs in patients with chronic liver…
4
Mins
31 Jan 2022
A Case Report on a Novel
PINK1
Gene Mutation in a Female with a Neurodegenerative Disorder
Parkinson’s disease (PD) is a progressive neurodegenerative disorder attributed to the loss of dopaminergic neurons in the substantia nigra.
11
Mins
27 Jan 2022
New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.
6
Mins
9 Dec 2021
Neurofibromatosis Type 1: Burden of Disease in Patients with Plexiform Neurofibromas
NF1 is an autosomal dominant disorder, arising from a mutation in the gene that encodes neurofibromin. It is a tumour-predisposing…
6
Mins
9 Dec 2021
Management and Multi-specialty Approach in the Evolving Treatment Landscape of Neurofibromatosis Type 1 Plexiform Neurofibromas
Neurofibromatosis Type 1 (NF1) is a rare disease, occurring in approximately 1 in 3,000 people. Among the numerous manifestations…
4
Mins
25 Nov 2021
Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations
At the 7th Congress of the European Academy of Neurology (EAN), held virtually in June 2021, real-world data on the efficacy and safety of…
7
Mins
21 Oct 2021
Assessing Disease Activity and Progression in Patients with Relapsing–Remitting Multiple Sclerosis: Interviews with Two Key Opinion Leaders
Multiple sclerosis is a common and chronic neurological disorder that affects over 2.8 million individuals worldwide every year…
12
Mins
19 Oct 2021
Cannabinoids in the Treatment of Epilepsy: A Review
Cannabidiol (CBD) comes from Cannabis sativa, which is a medicinal plant known to have several properties. Several types of extracts from…
3
Mins
8 Sep 2021
Interview: Claudio Bassetti
Ioannis Sfontouris | President of the European Academy of Neurology (EAN); Professor of Neurology and Head of the Neurology Department… %
8
Mins
3 Aug 2021
Motor Fluctuation Management in Parkinson’s Disease: Now and What Next?
Here the speakers present highlights of a virtual satellite symposium at the 7th Congress of the European Academy of Neurology…
3
Mins
3 Aug 2021
INTERVIEW: SERGIO BARANZINI
Both my parents were clinical biochemists, and ran their lab next to our house, so I grew up in between microscopes, electrophoretic apparatuses…
4
Mins
3 Aug 2021
INTERVIEW: KRISTIAN STEEN REDERIKSEN
Since medical school I have had a special interest in cognitive neurology and higher cortical functions, and actually started out doing a…
5
Mins
3 Aug 2021
A Case Report: Internal Carotid Artery Dissection Presenting as Hoarseness Secondary to Vocal Cord Palsy
Vocal cord paralysis or weakness can be a symptom of malignancy, caused by viral infection, iatrogenic, a result of trauma, idiopathic…
4
Mins
3 Aug 2021
Turner Syndrome and Craniosynostosis: An Unusual Combination
Turner syndrome (TS) is one of the most frequent chromosomal aberrations, caused by the partial or complete loss of one X chromosome…
5
Mins
3 Aug 2021
A Case of Subacute Combined Degeneration as a Manifestation of Pernicious Anaemia
The patient was admitted to the hospital for further study of the neurological changes, treatment of serious anaemia…
7
Mins
3 Aug 2021
Successful Management of Parsonage–Turner Syndrome with Steroids in the Post-acute Weakness Phase: A Case Report
Parsonage–Turner Syndrome (PTS) is a rare disease of the brachial plexus of unclear aetiology. The authors present a case of PTS with a rare combination of unilateral brachial plexus, phrenic nerve, and recurrent laryngeal nerve injuries.
24
Mins
30 Jun 2021
Clarity on Cannabinoid-Based Products in Medicine
This document aims to provide an overview of the clinical and regulatory challenges faced in the use of cannabinoid-based products in medicine, without becoming a comprehensive humanity review of the literature on the medical possibilities of cannabinoids.
10
Mins
17 Jun 2021
Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey
Non-dystrophic myotonias (NDM) manifest as delayed muscle relaxation (myotonia) leading to muscle stiffness that may diminish or worsen…
4
Mins
26 Apr 2021
A Successful Treatment of Chronic Migraine with Hyperbaric Oxygen Therapy
Migraines involve intense head pain, which severely affects the activities of daily living, and is the is the third most common disease in the world…
9
Mins
10 Dec 2020
Clinical Profile and Outcome of Children with Acute Central Nervous System Infection in Kerala, India
Infection of the central nervous system is a significant cause of morbidity and mortality in children.
9
Mins
9 Dec 2020
The Role of Sphingosine 1-Phosphate Receptor Modulators in the Treatment of Multiple Sclerosis
Neurologists are familiar with S1P receptor modulators as a class, largely based on several years’ experience with fingolimod. Siponimod and ozanimod…
11
Mins
3 Nov 2020
Empowering Physicians to Advance the Future of Alzheimer’s Disease Management and Care
This series of four talks was aimed at providing healthcare professionals (HCP) with an understanding of the need for early diagnosis of AD to enable refined care
4
Mins
13 Jul 2020
Interview: Professor Michael Barnes
I became interested whilst working in multiple sclerosis clinics roughly 20 years ago. Some of my patients came to the clinic and told me that they…
11
Mins
13 Jul 2020
Moving from The Periphery to The Core of The Matter – Where Does Opicapone▼ Fit in Parkinson’s Disease?
Presented here are highlights of a virtual satellite symposium from the European Academy of Neurology (EAN) 2020 Virtual Congress…
4
Mins
13 Jul 2020
An Evaluation of the Studies on the Therapeutic Effects of Yoga in People with Dementia
The global population is ageing, and the prevalence of dementia is increasing. Current conventional drug therapy lacks efficacy; therefore…
12
Mins
13 Jul 2020
Editor's Pick: Current Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders
The human body harbours a diverse community of symbiotic, commensal, and pathogenic micro-organisms including bacteria, viruses, and fungi…
15
Mins
13 Jul 2020
Clinical Controversies in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative condition with few effective treatments. New techniques have been developed to provide a more accurate diagnosis, earlier in the disease course.
11
Mins
13 Jul 2020
Neuroinfections: Presentation, Diagnosis, and Treatment of Meningitis and Encephalitis
This article serves as a review of the approach to a patient with suspected neurological infection with an emphasis on clinical presentation, diagnosis, and treatment of the major causes of meningitis and encephalitis.
3
Mins
13 Jul 2020
Case Report of Schwannomas: Benign Tumour of the Peripheral Nerve Sheath
Schwannomas are benign, painless, firm nodules, 1–2 cm in diameter, that develop from the Schwann cells of peripheral nerve sheaths…
6
Mins
13 Jul 2020
Neuroinflammation: A Common Line Between the Wnt Pathway and Toll-Like Receptors
Neurodegenerative disorders constitute a worldwide concern attributable to the ageing of the human population.
7
Mins
13 Jul 2020
Unilateral Facial Palsyin Guillain–Barré Syndrome, A Hyperreflexic Variant Case
Guillain–Barré syndrome (GBS) is a form of rapidly progressive, acute inflammatory demyelinating polyradiculopathy.
13
Mins
23 Jun 2020
National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management
The ‘treatment gap’ for people with epilepsy is a global health emergency; this is the number of people who need epilepsy treatment but are not…
5
Mins
23 Jun 2020
A Case Report: Isolated Pontine Lesion in Hypertensive of a Pregnant Patient with Idiopathic Thrombocytopenia
Posterior reversible encephalopathy syndrome (PRES) is a clinical condition characterised by headache, visual disturbances, seizures, and confusion…
11
Mins
12 Dec 2019
Improving Intravenous Immunoglobulin Dosing in Autoimmune Neuropathies
This symposium took place on Monday 24th June 2019, as part of the 2019 Peripheral Nerve Society (PNS) Annual Meeting in Genoa, Italy.
7
Mins
13 Aug 2019
Optimism and Opportunities with Anti-CGRP Biologics in Migraine: Where Are We Today?
Migraine is a complex neurological disorder with an approximate global prevalence of 15%. It is characterised by a moderate-to-severe unilateral…
10
Mins
13 Aug 2019
Editor's Pick: Classification of Pontocerebellar Hypoplasia: Where does it End?
Pontocerebellar hypoplasia (PCH) describes a heterogeneous group of rare neurodegenerative diseases. PCH is characterised by hypoplasia of the cerebellum…
10
Mins
13 Aug 2019
Seizures in Childhood: Aetiology, Diagnosis, Treatment, and What the Future May Hold
Seizures are one of the most common medical problems affecting children, and epilepsy is the most common chronic neurological condition in children…
9
Mins
13 Aug 2019
At Physiologically Relevant Concentrations, Valproic Acid and Lithium Carbonate Reduce Oxidative Stress in Human Astrocytoma Cells
There is growing evidence for the connection between mitochondrial alterations in psychiatric disorders and psychiatric symptoms in mitochondrial…
11
Mins
13 Aug 2019
A Possible Explanation For Neurodegenerative Disease
In 2015, 46.8 million individuals worldwide had a neurodegenerative disease, with 4.6 million new cases being recorded each year.1 Many of these…
10
Mins
13 Aug 2019
The Autonomic Nervous System: Delineating Historical Landmarks and Their Translation to Target Autonomic Dysfunctions in Multiple Sclerosis
Multiple sclerosis (MS) is first perceived as a disease affecting voluntary motor and sensory systems. The autonomic dysfunctions associated…
10
Mins
13 Aug 2019
Acquired Language Disorders in Bilinguals
The cases of bilingual aphasia are increasing worldwide, as they also reflect the globally increasing number of individuals speaking more than two…
8
Mins
17 May 2019
Current Issues in Multiple Sclerosis: Selected Highlights of the ECTRIMS 2018 Congress
It is well established that pregnancy has a clear impact on disease activity in multiple sclerosis (MS); the relapse rate decreases during…
7
Mins
10 Jan 2019
The 5th International Symposium on Collaterals to the Brain (Collaterals 2018)
The 5th International Symposium on Collaterals to the Brain (Collaterals 2018) took place on 6–8th November 2018 in Los Angeles, California, USA.
6
Mins
13 Dec 2018
Management of Fluctuating Parkinson’s Disease: From Science to Clinical Wisdom
This symposium took place at the 4th Congress of the European Academy of Neurology (EAN) 2018 in Lisbon, Portugal, and focussed on the effective…
6
Mins
7 Aug 2018
Diagnosing Neuromuscular Diseases
The field of neuromuscular diseases (NMD) has evolved at an unprecedented speed over the last two decades. Due to advances in molecular genetics…
10
Mins
7 Aug 2018
Editor's Pick: Palliative Care in Neurology: Integrating a Palliative Approach to Amyotrophic Lateral Sclerosis Care
This narrative review examines connections between neurology, specialist palliative care, and an integrated palliative approach to care for people living…
10
Mins
7 Aug 2018
Behçet’s Disease and Neuro-Behçet’s Syndrome
Behçet’s disease is an idiopathic chronic relapsing multisystem vascular-inflammatory disease of unknown origin, which usually presents with orogenital ulceration and uveitis and is identified as the triple-symptom complex.
9
Mins
7 Aug 2018
Spatial Patterns of the Tau-Immunoreactive Inclusions in Eight Different Tauopathies are Consistent with the Spread of Pathogenic Tau
Tauopathies are a major group of neurodegenerative disorders characterised by the presence of tau-immunoreactive inclusions in the cytoplasm of neurons…
9
Mins
7 Aug 2018
Plasmapheresis for Neuromyelitis Optica: A Review from the Transfusion Medicine Specialist’s Perspective
Neuromyelitis optica is characterised by severe visual impairment and neurologic dysfunction, and aggressive plasmapheresis treatment is often recommended.
6
Mins
30 Jul 2018
Technological Innovation in Neuroradiology: An Interview with Dr Sanjay Prabhu
During the prestigious Neuro Convention conference, which took place at the ExCeL, London, UK from 6th–7th June 2018, the European Medical Group…
6
Mins
17 Jul 2018
Exercise and Physiotherapy in the Management of Parkinson’s: An Interview with Dr Katherine Baker
During a captivating 2 days at European Neuro Convention, an event which took place at the ExCel London from 6th–7th June 2018…
6
Mins
7 Jun 2018
Plotting a Better Pathway for Parkinson’s Disease: A New Composite Scale from My PD Journey
A clinical scale that takes a broader, deeper view of Parkinson’s disease (PD) symptoms is the latest milestone in a collaborative effort by My PD…
7
Mins
1 Mar 2018
Insomnia in the Ageing Population: Characterisation and Non-Pharmacological Treatment Strategies
Sleep problems represent a worldwide health concern among older adults, with an increasing prevalence of multimorbid conditions and a decreased quality…
8
Mins
10 Aug 2017
Editor’s Pick : Emerging Treatment Options in Migraine
Migraine is a leading cause of disability worldwide. Despite increasing knowledge about its pathophysiology and neurobiology over recent times, treatment…
3
Mins
10 Aug 2017
The Clinical Development of Cerebrolysin: New Approaches in Stroke Studies. A Commentary to the Cars Study
Additional efficacious treatment options for stroke are urgently needed as thrombolysis and endovascular thrombectomy are too rarely utilised due to the…
9
Mins
10 Aug 2017
Paediatric Primary Headache: Pharmacological and Non-Pharmacological Treatments
Headaches are common in children and adolescents, and are the most common pain complaint when seeking medical advice.
10
Mins
10 Aug 2017
Central Nervous System Disease Associated with Major Viral Haemorrhagic Fever Viruses of Public Health Importance: Challenges in Patient Diagnosis, Evaluation, and Management in Resource-Limited Settings
Viral haemorrhagic fever (VHF) viruses cause infectious diseases that are of public health importance. Billions of people from all over the world are at…
6
Mins
10 Aug 2017
Neurosyphilis: An Important Cause of Recurrent Strokes
Neurosyphilis can manifest as recurrent brain infarction, although not frequently, but can be challenging to diagnose due to atypical presentations.
5
Mins
10 Aug 2017
Focus on the Endogenous Cannabinoid System in Migraine
Migraine prophylaxis represents a better choice than symptomatic drugs, both for safety and for effectiveness.
10
Mins
1 Jun 2017
Comprehensive Assessment and Pharmacotherapy of Patients with Chronic Pain Syndrome Due to Diabetic Neuropathy and Postherpetic Neuralgia
Management of chronic pain, usually associated with comorbid conditions, remains challenging. General practitioners, together with multidisciplinary…
7
Mins
1 Jun 2017
Paradigm Shift for Thrombolysis for Patients with Acute Ischaemic Stroke, from Extension of the Time Window to the Rapid Recanalisation After Symptom Onset
Intravenous thrombolysis (IVT) and intra-arterial thrombolysis (IAT) are useful therapeutic tools to improve functional outcomes after recanalisation of…
10
Mins
2 Mar 2017
State-Of-The-Art Advances in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a severe and fatal muscle condition affecting young children. Without interventions, affected boys lose the ability…
8
Mins
2 Feb 2017
New Developments for Parkinson’s Therapy with COMT Inhibitors
Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. There are currently…
13 Dec 2016
Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimise Quality of Life
Parkinson’s disease is a complex, progressive neurodegenerative disorder associated with both motor and non-motor symptoms. Current treatment strategies…
3
Mins
22 Nov 2016
Delaying School Start Times to Boost Adolescent Academic Performance
Sleep is becoming an increasingly scarce commodity, especially among adolescents. For a teenager to perform at maximum cognitive levels, sleep…
3
Mins
12 Jul 2016
A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes
Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
12 Jul 2016
Brain Health: Translating Scientific Evidence Into Clinical Practice in Multiple Sclerosis
Brain volume loss (BVL) progresses more rapidly in patients with multiple sclerosis (MS) than in healthy individuals, and brain atrophy begins early in…
12 Jul 2016
Editor’s Pick: Clinical Significance of Apathy in Parkinson’s Disease
Apathy, or lack of motivation, is increasingly recognised as a major factor affecting quality of life and prognosis in Parkinson’s disease (PD)…
12 Jul 2016
Development and Translation of Therapies for Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterised by widespread loss of lower motor neurons from the spinal…
12 Jul 2016
Wilson’s Disease: An Inherited, Silent, Copper Intoxication Disease
Wilson’s disease is a rare, autosomal recessive, genetic, copper overload disease, which evokes multiple motor or neuropsychiatric symptoms and liver…
12 Jul 2016
Multiple Sclerosis: Where Do We Go From Here?
Multiple sclerosis (MS) is the most common cause of neurological disability in young populations after trauma and represents a significant personal…
12 Jul 2016
Whole Spectrum of Natural Progression of Haemangioblastoma Seen Within a Single Patient: A Very Rare Case Report and Literature Review
This paper reports a rare case of sporadic variation of haemangioblastoma (HB) presenting as multiple lesions within the posterior fossa. A whole…
12 Jul 2016
Advances in the Management of Transient Ischaemic Attack and Stroke
Among many important advances in the management of transient ischaemic attack (TIA) and stroke are: the updated definition of TIA; risk stratification…
5 Apr 2016
The Multifactorial Background of Emerging Viral Infections with Neurological Manifestation
The events of the past year have highlighted the continuing importance of emerging virus infections on the diagnosis and treatment of neurological disease.
26 Jan 2016
How I Treat: Multiple Sclerosis
Multiple sclerosis (MS) is a neurological disorder, characterised by inflammation and neurodegeneration.
6 Aug 2015
Non-Oral Drug Delivery Strategies: From Early Diagnosis to Advanced Treatments
This educational symposium, sponsored by Britannia Pharmaceuticals Limited, was held during the 1st Congress of the European Academy of Neurology (EAN)…
6 Aug 2015
Hypothalamic–Pituitary Alterations in Patients With Neurosarcoidosis
Sarcoidosis is a non-caseating, granulomatous inflammatory disorder that can affect the central nervous system (CNS), including the hypothalamic–pituitary..
Loading posts...
« Previous
1
…
15
16
17
18
19
…
21
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View